Prospective in silico study of the feasibility and dosimetric advantages of MRI-guided dose adaptation for human papillomavirus positive oropharyngeal cancer patients compared with standard IMRT

Prospective in silico study of the feasibility and dosimetric advantages of MRI-guided dose adaptation for human papillomavirus positive oropharyngeal cancer patients compared with standard IMRT. Mohamed, A. S. R.; Bahig, H.; Aristophanous, M.; Blanchard, P.; Kamal, M.; Ding, Y.; Cardenas, C. E.; Brock, K. K.; Lai, S. Y.; Hutcheson, K. A.; Phan, J.; Wang, J.; Ibbott, G.; Gabr, R. E.; Narayana, P. A.; Garden, A. S.; Rosenthal, D. I.; Gunn, G. B.; Fuller, C. D.; Group, M. D. Anderson MRLinac Development Working. Clin Transl Radiat Oncol. 2018; 11-18: p.11-18. doi:10.1016/j.ctro.2018.04.005
Article